Paritaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise review
Trana Hussaini1,2 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; 2Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, BC, Canada Abstract: The treatment for chronic hepatitis C has been revolutionized with the development of direct-acting ant...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Dove Medical Press
2016-05-01
|
| سلاسل: | Hepatic Medicine: Evidence and Research |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.dovepress.com/paritaprevirritonavir-ombitasvir-and-dasabuvir-the-3d-regimen-for-the--peer-reviewed-article-HMER |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|